The Pre-Analytical Phase: Sources of Error and Quality Foundations

What Is the Pre-Analytical Phase?

Laboratory testing is divided into three phases: pre-analytical, analytical, and post-analytical. The pre-analytical phase covers everything that happens before the specimen is placed in the analyzer — from the moment a test is ordered through patient preparation, collection, labeling, transport, and specimen processing. Research consistently shows that the majority of laboratory errors originate in this phase, making it the most critical area for a phlebotomy technician to master.

As a phlebotomy technician, you work almost entirely within the pre-analytical phase. Understanding where errors can enter the process — and how to prevent them — is fundamental to patient safety and the reliability of every result that guides a clinician's decision.

Why Pre-Analytical Errors Matter

A laboratory result is only useful if it accurately reflects the patient's true physiological state. When a pre-analytical error occurs, the result may be falsely elevated, falsely decreased, or completely invalid. A clinician acting on a wrong result may order unnecessary treatment, miss a diagnosis, or withhold a medication that is urgently needed. The patient bears the consequence of an error that happened before the analyzer was ever involved.

The CLSI (Clinical and Laboratory Standards Institute) publishes GP41, the authoritative guideline for venous blood collection. Familiarizing yourself with its principles is part of professional practice and is referenced by certifying bodies including NHA, AMT, and ASCP.

Six Major Sources of Pre-Analytical Error

1. Patient Preparation Errors

Many tests require specific preparation. Fasting glucose and lipid panels require the patient to have fasted, typically for a defined period. Collecting a fasting specimen from a patient who just ate will produce a falsely elevated glucose. Strenuous exercise before collection can alter results such as potassium, creatine kinase, and lactic acid. Always verify patient preparation before drawing.

2. Patient Identification and Labeling Errors

Mislabeling is one of the most dangerous errors in phlebotomy. A specimen labeled with the wrong patient's name or medical record number means results are reported to the wrong chart. This can lead to incorrect treatment for two patients simultaneously. Labels must be applied at the bedside or draw site immediately after collection while the patient is still present. Never pre-label tubes.

3. Wrong Tube or Additive

Blood collection tubes contain specific additives matched to the test ordered. Using the wrong tube — for example, collecting a coagulation study in an EDTA tube instead of a sodium citrate tube — produces results that are analytically meaningless for that test. EDTA chelates calcium, which is essential to the coagulation cascade; results from such a specimen cannot be reported. Always verify the tube color and additive against the test requisition.

4. Hemolysis

Hemolysis occurs when red blood cells are damaged and release their contents — especially potassium and certain enzymes — into the serum or plasma. Common causes include using too small a needle for the draw, excessive suction, vigorous shaking of the tube, drawing through a hematoma, or allowing the specimen to sit in temperature extremes. A hemolyzed specimen can falsely elevate potassium, AST, LDH, and other analytes. Many hemolyzed specimens must be recollected, delaying care and requiring another venipuncture.

5. Incorrect Order of Draw

Tubes must be collected in a standardized sequence — the order of draw — to prevent additive carryover between tubes. For example, if a coagulation tube (sodium citrate, light blue) is drawn after a tube containing EDTA, microscopic amounts of EDTA can contaminate the citrate tube and invalidate coagulation results. Following the CLSI-recommended order of draw every time prevents this category of error.

6. Transport and Processing Errors

After collection, how a specimen is handled determines whether it remains viable for testing. Specimens that must be kept at body temperature (such as cold agglutinin studies) or chilled (such as ammonia or arterial blood gases) will yield erroneous results if transported incorrectly. Allowing a specimen to sit unprocessed beyond acceptable time limits permits ongoing cellular metabolism to alter analyte concentrations. Centrifuge speed, time, and temperature must also meet laboratory specifications.

Additional Variables to Know

• Tourniquet time: Prolonged tourniquet application (generally beyond one minute) causes hemoconcentration, artificially concentrating large molecules and cells.
• Site selection: Drawing from an arm with a running IV introduces dilution or infusion fluid contamination.
• Tube fill volume: Underfilling a sodium citrate tube changes the blood-to-anticoagulant ratio and directly affects coagulation test results.
• Patient position: Going from lying to sitting to standing shifts fluid between compartments and can affect certain analyte concentrations.

Safety First

Every step in the pre-analytical phase has a patient-safety dimension. Verify the patient's identity using at least two identifiers before every draw. Never collect a specimen you are not certain belongs to the right patient. If you discover a labeling error after the fact, report it immediately through your facility's established process — do not attempt to correct a label yourself after leaving the patient's side. Scope of practice requires you to act within your training and to escalate concerns to a supervising professional when in doubt.

Connecting to Your Credential Exam

CPT certification exams from NHA, AMT, and ASCP include questions on specimen collection, handling, and processing. Understanding the pre-analytical phase — and being able to categorize errors by type and consequence — is directly tested content. The cause-and-effect diagram and case-study activities in this lesson build exactly the analytic thinking those questions require.